Zimmer Biomet Receives FDA Clearance for Enhanced ROSA Knee with OptimiZe System
Zimmer Biomet Holdings, a global leader in medical technology, has received US Food and Drug Administration (FDA) 510(k) clearance of its ROSA Knee with OptimiZe, an enhanced version of its ROSA Knee System designed to deliver greater personalisation, accuracy and reproducibility in robotic-assisted total knee replacement surgery.
ROSA Knee With OptimiZe | 15/11/2025 | By Dineshwori
We use our own and third party cookies to produce statistical information and show you personalized advertising by analyzing your browsing, according to our COOKIES POLICY. If you continue visiting our Site, you accept its use.
More information: Privacy Policy